INFORMATION COLLECTIONS TO ADVANCE STATE, TRIBAL, LOCAL AND
TERRITORIAL (STLT) GOVERNMENTAL AGENCY AND SYSTEM PERFORMANCE,
CAPACITY, AND PROGRAM DELIVERY
OMB No. 0920-0879; Exp. 01/31/2024
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
SUPPORTING STATEMENT A
06/14/2023
Program Official
Karen Mumford, PhD
Associate Director for Science, Office of Science and Evaluation
Division of Jurisdictional Support
Centers for Disease Control & Prevention
11 Corporate Blvd NE, MS: V18-1
Atlanta, Georgia 30329
Office - 404-498-0223
TABLE OF CONTENTS
|
3 |
|
6 |
|
8 |
|
8 |
|
8 |
|
8 |
|
9 |
|
9 |
|
9 |
|
9 |
|
9 |
|
9 |
|
10 |
|
10 |
|
11 |
|
11 |
|
11 |
|
11 |
List of Attachments |
12 |
References |
12 |
Goal:
This is a three-year extension request for an approved generic ICR.
The purpose of this generic clearance is to advance state, tribal,
local, and territorial (STLT) governmental agency system
performance, capacity, and program delivery.
Intended
use of the resulting data: Information
will be used to assess situational awareness of current public
health emergencies; make decisions that affect planning, response,
and recovery activities of subsequent emergencies; fill CDC gaps in
knowledge of programs and/or STLT governments that will strengthen
surveillance, epidemiology, and laboratory science; improve CDC’s
support and technical assistance to states and communities.
Methods
to be used to collect CDC
will conduct data collections across a range of public health
topics utilizing standard modes of administration including online,
telephone, in-person data collections.
The
subpopulation to be studied:
The respondent universe is comprised of STLT governmental staff and
delegates acting on behalf of a STLT agency involved in the
provision of essential public health services in the United States.
The STLT agency is represented by a local, state, tribal or
territorial governmental entity or delegate with a task to improve
the public’s health.
How
data will be analyzed:
Analysis will include descriptive and inferential statistics.
Linking collected data to existing data sources by non-personal
identifiers (state, county, city names, etc.) may be used to
increase the overall utility of a proposed data collection. All
data analysis will be conducted under the advice of a CDC
statistician/data analyst.
Part A. JUSTIFICATION
Circumstances Making the Collection of Information Necessary Background
The Centers for Disease Control and Prevention (CDC) is requesting approval for an extension to this “generic” clearance under the authority of Section 301 of the Public Health Service Act (42 USC Sec. 301 [241]) (Attachment A). The purpose of this generic clearance is to advance state, tribal, local, and territorial (STLT) governmental agency system performance, capacity, and program delivery.
The 0920-0879 was first approved in 2011, has been extended four times. The most current version was approved on 01/13/2021 and will expire on 01/31/2024. All elements within this extension request remain the same as the currently approved generic clearance.
Background
CDC’s mission is to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, prevention of disease, injury and disability, and preparedness for new health threats. CDC seeks to accomplish its mission by collaborating with partners throughout the nation and the world to monitor health, detect and investigate health problems, conduct research to enhance prevention, develop and advocate sound public health policies, implement prevention strategies, promote healthy behaviors, foster safe and healthful environments, and provide leadership and training.
CDC priorities include addressing the leading causes of disease, injury, and disability in the United States, including a focus on tobacco control; improving nutrition, physical activity, and food safety; reducing healthcare-associated infections; preventing motor vehicle injuries; preventing teen pregnancy; and preventing HIV. Approaches to improvements include — strengthening surveillance, epidemiology, and laboratory science; health promotion and disease prevention across the lifespan; better supporting efforts in states and communities; and to pursuing policies that have an impact on the population’s health. As such, CDC’s relationship with state, local, tribal, and territorial (STLT) governmental staff and their delegates is key to its health promotion, disease prevention, and emergency preparedness responsibilities.
National initiatives support the need for this generic ICR, both in content and with respect to increasing access and use of data, as evidenced by the following:
National Prevention Strategy (NPS): the purpose of the NPS is to increase the number of Americans who are healthy at every stage of life. This goal is achieved by: 1) strengthening state, tribal, local, and territorial public health departments to provide essential services; 2) enhancing cross-sector collaboration in community planning and design to promote health and safety; 3) supporting integration of prevention and public health skills into health care professional training. (1)
The Institute of Medicine (IOM) report, ‘Primary Care and Public Health: Exploring Integration to Improve Population Health, emphasizes the overlap between public health and primary care roles and functions. This overlap or integration of public health and primary care is characterized as a continuum that spans mutual awareness, cooperation, collaboration, and partnership. (2)
HHS Strategic Plan: One of five main strategic goals of the HHS Strategic Plan describes the need to ensure efficiency, transparency accountability and effectiveness. A component of this goal emphases the need to enhance access to and use of data to improve HHS programs and support improvements of the health and well-being of the American people. (3)
This application is for a framework under which individual data collections could then be expeditiously approved. This framework characterizes the population from whom the data is to be collected and the methods that would be used to collect the data, as well as the topics about which CDC usually collects such data. Individual information collection requests will be submitted to OMB and will include the actual data collection instruments and will describe the specific data collection goal, design, and sampling and analysis plans.
Circumstances instigating a collection will vary for each data collection. Examples of type of data collections include (but are not limited to):
assessing STLT and delegate resource and program capacities
identifying technical assistance needs
assessing workforce development and training needs
identifying resource needs and constraints within STLT programs
assessing and developing communication tools to meet STLT needs
informing quality improvement activities within CDC programs
identifying strengths and barriers in STLT and CDC programs
tailoring CDC products and services to STLT needs
quick assessment of program impact
prioritizing CDC program activities
preparing and evaluating of Health and Human Services (HHS) requests and CDC funding opportunity announcements
developing of policies and laws
issues of impact, data gaps and linking new or existing datasets, need for current, time sensitive information, and information relevant to specific priorities of HHS and CDC will provide the basis for initiation of a collection and many more.
Proposed data collections will conduct an extensive search for existing data collected by CDC or its partners to ensure there is no duplication of effort. It is important to note that CDC efforts under this generic clearance will not be duplicative of information collections already conducted by ASTHO, NACCHO and other public health organizations. The resulting burden is an upper-bound estimate and will be adjusted as appropriate as CDC uses the collection.
Value of 0920-0879 Generic Information Collection Request
The 0920-0879 generic information collection request is a valuable mechanism to the Agency. It provides an umbrella approval mechanism under which individual data collections that use similar methods and are for a similar purpose can be approved. The value of 0920-0879 can be seen in the following results*:
0920-0879 facilitated the approval of 14 unique genICs within the current approval period to date (see Attachment B).
On average, OMB approval was granted to 0920-0879 information collections within 50 days of submission.
100% of CDC programs using 0920-0879 report that they would use it again in the future. CDC programs benefit from a generic clearance mechanism that allows for timely approval of information collections, however does not impose restrictions on modes of data collection (e.g., online assessment, focus groups), use of statistical methods for sampling or analysis, or publishing of results.
* Results reflective of current 0920-0879 approval from 1/13/2021 through 06/09/2023.
Information was collected from state, tribal, local, and territorial governmental entities or delegates with a task(s) to improve the public’s health. Examples of delegates have included non-profit organizations, academic institutions, and private organizations that represent or act on behalf of STLT governmental entities to fulfil essential public health work.
As mentioned previously, the purpose of 0920-0879 is to advance state, tribal, local, and territorial (STLT) governmental agency and system performance, capacity, and program delivery. The success of 0920-0879 can be seen in the following examples of approved information collections:
Performance: the genIC “Improving Processes for Identifying and Reporting Disaster-Related Deaths: CDC Guidance Knowledge Assessment” (approved 9/16/22), aimed to assess the current practices, challenges, and capacity related to identifying and documenting disaster-related deaths. Results were used to inform recommendations for how CDC can improve disaster related death documentation, thereby increasing states’ performance in these areas.
Capacity: the genIC “Disease Intervention Specialist (DIS) Workforce Assessment” (approved 3/7/2023) aimed to gather information about the number and geographic distribution of infectious disease intervention professionals. The findings from this data collection were used to develop a national certification program for disease intervention professionals, helping to increase capacity in these areas.
Program Delivery: the genIC “Early Care and Education (ECE) State Indicator Assessment 2022” (approved 1/20/23) aimed to gather information about state-level obesity prevention activities in the early care and education (ECE) setting. This information was used to produce CDC’s second ECE State Indicator Report (ECE SIR), which describes state-level prevention efforts and will allow states to see how they align with the CDC ECE obesity prevention framework and track their progress from the first ECE SIR.
Principal investigators across CDC have utilized the 0920-0879 generic clearance to collect information on a variety of topical areas including environmental health, infectious disease, public health preparedness and response, chronic disease, and injury and violence prevention, among others.
Purpose and Use of the Information Collection
The respondent universe is comprised of STLT governmental staff and delegates acting on behalf of a STLT agency involved in the provision of essential public health services in the United States. The STLT agency is represented by a local, state, tribal or territorial governmental entity or delegate with a task to improve the public’s health.
The scope of data collection is limited to responsibilities and duties of governmental staff or delegates acting in their official capacity in delivering essential public health services. Thus, individual data collections that require institutional review board review are not covered. OMB will decline individual data collection requests if it includes respondents that are governmental staff or delegates with official tasks other than public health. The collection will include the following categories of STLT governmental officials: 1) State, Tribal, Local, and Territorial governmental staff or delegate; and 2) Local/County/Municipal/City government staff or delegate.
State, territorial, and tribal government agency staffs or delegates are in a unique position to provide CDC with the following information for a given jurisdiction: public health threats, status of public health infrastructure, workforce and financing at state, territorial and tribal levels. For that reason, CDC will collect data from that category if, for example, the assessment of the magnitude of a particular public health problem is needed (surveillance), or when assessment of the jurisdiction’s capacity to respond to a particular health problem (assessment and performance management) is warranted, etc.
County and municipal/city governmental staffs or delegates are at the forefront of public health service delivery and emergency response. Examples of data collections for that category may include, but not be limited to assessment of their performance in provision of public health services, progress they are making in accreditation process, new policy development initiatives, etc.
CDC will conduct data collections across a range of public health topics related to essential public health services, using standard modes of administration (e.g., phone, web, e-mail, and in person). Information will be used to assess situational awareness of current public health emergencies; make decisions that affect planning, response, and recovery activities of subsequent emergencies; fill CDC gaps in knowledge of programs and/or STLT governments that will strengthen surveillance, epidemiology, and laboratory science; improve CDC’s support and technical assistance to states and communities.
In general, we expect that these collections will be solicited from governmental staff or delegate, in a category (e.g., all epidemiologists, food safety program manager, laboratory technicians or delegate, or to the subset of professional staff) for which a particular health problem is thought to be relevant. This collection of information will employ statistical methods for analysis as described in section B.
Data collections will gather information on administration, quality, quantity, improvement, inputs, activities, outputs, and outcomes related to delivery of essential public health services. Questions will be formulated around one or more of the three themes of the ten essential public health services listed below.
Assessment
Monitoring health status to identify community health problems
Diagnosing and investigating health problems and health hazards in the community
Evaluating effectiveness, accessibility, and quality of personal and population-based health services
Policy Development
Development of policies and plans that support individual and community health efforts
Enforcement of laws and regulations that protect health and ensure safety.
Research for new insights and innovative solutions to health problems
Assurance
Linking people to needed personal health services and assure the provision of health care when otherwise unavailable
Assuring a competent public health and personal health care workforce
Informing, educating, and empowering people about health issues
Mobilizing community partnerships to identify and solve health problems
In general, CDC does not expect these collections to yield data that can be generalized but will produce needed information regarding important health topics that affect state and local public health issues. CDC expects to use these findings to understand better the range of experiences among state, local, tribal, and territorial governmental staff or delegate, and as one of many inputs into decision making and/or program management or assessment.
CDC will submit the specific information collections to OMB for review as individual Information Collections (ICs) under this general Generic clearance framework. Individual submissions will include the purpose of the collection, description of sample, target respondent, questions to be asked, and response burden. OMB will review and approve an individual IC in an expedited manner. However, if the specific information collection falls outside the scope of the generic clearance or is otherwise inconsistent with the terms of the generic clearance, OMB will return the proposed information collection to the agency for additional consideration or require that the full PRA process be followed, including public notice and comment, for the review and approval of that information collection.
Use of Improved Information Technology and Burden Reduction
Data collections will be conducted using the most current modes of data collection, including web-based instruments, focus groups, phone or in-person interviews or other modes applied to specific national assessments. Though these technologies will be used by many of the individual projects in this data collection, the nature of many of these proposed activities typically requires direct interaction between respondents and project staff, especially in the case of qualitative interviewing and cognitive testing. Also, in cases when respondents do not have access to electronic means of communication, a paper-based data collection will be implemented on a limited basis.
Efforts to Identify Duplication and Use of Similar Information
CDC recognizes and understands the fact that many collection requests are made to governmental health agencies, their delegates and thus intends to use this generic clearance judiciously to ensure only the most relevant collections are undertaken and that they are not duplicative of other efforts. CDC will require the program to determine whether the information already exists.
Impact on Small Businesses or Other Small Entities
No small businesses will be involved in this data collection
Consequences of Collecting the Information Less Frequently
The purpose of CDC’s request for this generic clearance is to ensure collection of data that is not otherwise available in current, time sensitive or relevant formats to specific or emergent priorities of HHS and CDC. Specifically, without this data there would be:
No timely feedback regarding effectiveness of CDC’s support and technical assistance to governmental public health agencies.
Less effective interventions and data-driven decisions that need to be often made between CDC and state, tribal, local, and territorial governmental health agencies in an expedited manner during emergencies and disease outbreaks.
Persistent gaps in other extant information collections, because of limited timing, content, or respondent focus, i.e., CDC will not be able to complement data collection activities of other entities
Limitations to effective and timely assessment of capacities of governmental agencies to fulfill their public health mission.
Existing data collections efforts have several limitations that necessitate need for this generic clearance request. For example:
Public health infrastructure data collections by CDC partners organizations (NACCHO) are conducted only every 2 years and thus have limited utility for CDC from the point of view of program monitoring and assessment, which usually require more frequent data collection.
None of the existing data collections include collection of data that is needed to evaluate many CDC programs and their unique needs.
Data needed to assure accountability of CDC investments in public health infrastructure through cooperative agreement mechanisms is not routinely collected.
Data needed to accommodate requests from HHS and Congress may not be available in currently run data collections of state and local government staff or delegates delivering essential public health services.
There are no legal obstacles to reduce the burden.
Special Circumstances Relating to the Guidelines of 5 CFR 1320.5
There are no special circumstances with this information collection package. This request fully complies with the guidelines of 5 CFR 1320.5.
Comments in Response to the Federal Register Notice and Efforts to Consult Outside the Agency
A 60-day Federal Register Notice was published in the Federal Register on January 23, 2023, Vol. 88, No. 14, pp 3991-3992 (see Attachment C). One non-substantive comment was received (see Attachment C-2). There were no efforts to consult outside the agency. No changes were made to the supporting statement or data collection instruments.
Explanation of Any Payment or Gift to Respondents
CDC will not provide payments or gifts to respondents.
Protection of the Privacy and Confidentiality of Information Provided by Respondents
The Privacy Act does not apply to this data collection. State, tribal, local, and territorial government agency staffs or delegates will be speaking from their official roles. If asked to provide any identifiable information, it will relate to their official duties (e.g., title, professional email address). All identifiable information will be securely stored. All results will be reported in the aggregate with all identifiable information removed.
Institutional Review Board (IRB) and Justification for Sensitive Questions
This data collection is not research involving human subjects. Therefore, IRB approval is not applicable.
No sensitive information will be collected. This data collection is not research involving human subjects.
Estimates of Annualized Burden Hours and Costs
The burden is calculated based on the assumption of querying at most 100% of all available state, territorial (800) and county (3,000) health officials/employees and a representative sample of at most 100 municipal/city employees. An estimate of 800 is made based on 50 states, 8 territories, 574 federally recognized tribes, and additional room for various positions in health department (chronic disease, lab, infectious, etc.). CDC estimates that it will conduct up to 40 queries with State, territorial or tribal health officials/employees. This includes all state, local, gov’t staff, the state programs, and the delegates. These are upper limit parameters assumed for the purpose of calculation of the total burden. The actual number of respondents in a data collection and number of queries per respondent will vary depending on the purpose of each individual generic collection request. The universe of respondents is described in section B.1 The total annualized burden hours of 54,000 is based on the following estimates. Please note, these estimates are for one year.
An average hourly salary of approximately $23.23 is assumed for all respondents, based on the Bureau of Labor Statistics’ National Occupational Employment and Wage Estimates.1 Because of the scope of this generic clearance and the variety of the types of participants, the average salary was utilized rather than attempting to estimate salaries for groups of audiences. With a maximum annual respondent burden of 54,000 hours, the overall annual cost of respondents’ time for the proposed collection is estimated to be a maximum $1,254,420 (54,000 hrs. x $23.23).
Table A-12: Estimated Annualized Burden Costs to Respondents
Type of Respondent |
No. of Respondents |
No. of Data collections per Respondent Type |
Average Burden per Respondent (in Hours) |
Total Burden Hours (annual) |
Hourly Wage Rate |
Total Respondent Costs |
State, Territorial, or Tribal government staff or delegate |
800 |
30 |
1 |
24,000 |
$23.23 |
557, 520 |
Local/County/City government staff or delegate |
3,000 |
10 |
1 |
30,000 |
$23.23 |
696,900 |
Total |
|
|
|
54,000 |
|
1,254,420 |
Estimates of Other Total Annual Cost Burden to Respondents or Record Keepers
There will be no direct costs to the respondents other than their time to participate in each information collection.
Annualized Cost to the Government
There are no equipment or overhead costs. The only cost to the federal government is the salary of CDC staff (or contractors) supporting the data collection activities and associated tasks. GenICs will be prepared by contractors or CDC staff (FTE). An FTE manager will review all data collections. Usability teams will vary across CDC teams but typically an FTE and contractor will work together on data collection preparations, conducting the data collections, and analyzing data. Additionally, a senior level FTE will typically review and approve the activities. The amount of time staff and contractors spend on data collections will vary depending on the number of participants for each data collection, the number of questions.
A maximum number of 40 data collections a year was assumed for estimation purposes (35 web-based and 5 in-person). These are higher end estimates based on the number of requests and cleared genIC’s through this mechanism, as well as the number of inquiries that are received. It is assumed that the cost of in-person data collections will be 3 times higher than web-based. The estimated cost to the federal government is $92,950. Table A-14 describes how this cost estimate was calculated.
Table A-14: Estimated Annualized Cost to the Federal Government
|
|||
Staff or Contractor |
Average Hours per data collection |
Average Hourly Rate |
Average Cost |
FTE coordinator (GS-14) |
3 per data collection |
$54.42 |
$163/ data collection |
FTE instrument preparation, data collection, data analysis (GS-13) |
20 per data collection |
$46.06 |
$921/ data collection |
Contractor instrument preparation, data collection, data analysis (GS-12 equivalent) |
20 per data collection |
$38.73 |
$775/ data collection |
Average cost per information collection (web based) |
|
|
$1859 |
Average cost per information collection (in person) |
|
|
$5577 |
Estimated Total Average Annual Cost of 35 web-based and 5 in-person Information Collections |
|
|
$92,950 |
Explanation for Program Changes or Adjustments
This is an extension. All elements within this generic remain the same as the current approved generic clearance mechanism.
Plans for Tabulation and Publication and Project Time Schedule
Data collection will be ongoing.
Reason(s) Display of OMB Expiration Date is Inappropriate
CDC does not request exemption from display of the OMB expiration date.
Exceptions to Certification for Paperwork Reduction Act Submissions
There are no exceptions to the certification.
List of Attachments
ATTACHMENT A: Public Health Service Act (42 USC Sec. 301 [241]).
ATTACHMENT B: Approved genICs under 0920-0879
ATTACHMENT C: 60-Day Federal Register Notice
ATTACHMENT C-2: Public Comment
References
1. National Prevention Strategy (NPS): https://www.hhs.gov/sites/default/files/disease-prevention-wellness-report.pdf
2. Primary Care and Public Health: Exploring Integration to Improve Population Health; https://www.ncbi.nlm.nih.gov/pubmed/24851288
3. HHS Strategic Plan: https://www.hhs.gov/about/strategic-plan/index.html
4. Bureau of Labor Statistics’ National Occupational Employment and Wage Estimates: https://www.bls.gov/oes/current/oes_nat.htm
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Modified | 0000-00-00 |
File Created | 2024-10-28 |